New drug duo aims to shrink tumors before chemo in aggressive breast cancer
Disease control
Recruiting now
This study is testing whether a new two-drug immunotherapy combination can shrink tumors in patients with stage II or III triple-negative breast cancer before they start standard chemotherapy. The trial will enroll 12 patients who have not yet received any treatment for their can…
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC